3-Sialyl galactose (sodium salt)—a key sugar chain unit for cell communication 83563-61-5

3-Sialyl galactose (sodium salt) (N-acetylneuraminyl-(2-3)-galactose) is a core oligosaccharide structure that is widely present in glycoproteins and glycolipids on the surface of eukaryotic cells. As an important molecule in glycobiology research, it not only plays a key role in cell recognition, signal transduction and immune regulation, but is also a central participant in physiological and pathological processes such as pathogen infection, inflammatory response and cancer development. With the rise of glycoscience in the field of biomedicine, this structural unit is becoming the focus of the development of new diagnostic tools and therapeutic strategies, and its importance is comparable to the revolutionary role of nucleic acid-modifying molecules in gene therapy.

Chemical Information

Chemical name: N-acetylneuramidyl-(2-3)-galactose

Common name: 3-Sialyl galactose (sodium salt)

Chemical formula: C17H29NO14

Molecular weight: 471.41 g/mol

CAS number: 83563-61-5

Category: Oligosaccharides

Structural features

3-Sialogalactose (sodium salt) has unique structural characteristics, allowing it to exert specific functions in biological systems:

α2-3 glycosidic bond connection: Sialic acid (N-acetylneuraminic acid) is connected to the hydroxyl group of galactose through α2-3 glycosidic bond, forming a disaccharide unit with a clear spatial orientation. This bonding mode is in contrast to the common α2-6 linkage, which determines the topological conformation of the sugar chain and the specificity of interaction with receptor proteins, playing a key role in tissue distribution and pathogen tropism.

Charged and hydrophilic properties: The carboxyl group of the sialic acid residue is negatively charged at physiological pH, and the sodium salt form further enhances the water solubility and chemical stability of the compound. This negative charge mediates electrostatic interactions, promotes repulsion or adhesion events on the cell surface, and affects processes such as cell migration and immune synapse formation.

Conformational dynamics and recognition diversity: The conformational flexibility of sugar rings allows them to fit into a variety of protein binding pockets, such as lectins, antibodies, and viral hemagglutinins, thereby participating in complex molecular recognition networks. This dynamic structure enables 3-sialogalactose to act as a "molecular switch" to regulate the opening or closing of signaling pathways.

Main applications and advantages

Cornerstone of cell surface biology and glycomics research

As the terminal structure of the cellular glycocalyx, 3-sialogalactose is an ideal model for exploring cell-cell and cell-matrix interactions. Its expression regulation in embryonic development, neurogenesis, immune cell trafficking, and stem cell differentiation provides key clues for understanding developmental biology and immunology. By studying this structure, scientists can unravel how glycosylation affects protein folding, stability, and function, thereby revealing the mechanisms of disease-related glycosylation abnormalities.

Analysis of pathogen infection mechanisms and development of antiviral strategies

Many viruses and bacteria utilize sialylated sugar chains on the cell surface as entry portals. For example, the hemagglutinin protein of influenza viruses specifically recognizes α2-3 or α2-6 linked sialogalactose, with avian influenza viruses (such as H5N1) mainly targeting α2-3 bonding, while human influenza viruses (such as H1N1) prefer α2-6 bonding. Pathogens such as rotavirus and coronavirus rely on similar mechanisms. Using 3-sialogalactose as a competitive inhibitor or research ligand can provide in-depth analysis of infection dynamics and guide the design of broad-spectrum antiviral drugs, vaccine adjuvants or diagnostic reagents, such as the development of sialidase inhibitors to block virus release.

Biomarkers and precision medicine targets in inflammation and cancer

During the inflammatory process, sialylated sugar chains participate in leukocyte rolling, migration and cytokine secretion, regulating innate and adaptive immune responses. In cancer, tumor cells often overexpress the α2-3 sialogalactose structure, which is related to epithelial-mesenchymal transition, metastatic potential and immune evasion, and is found in various malignant tumors such as breast cancer, colon cancer and pancreatic cancer. Therefore, this structure could serve as a potential biomarker in liquid biopsy or tissue imaging. Intervention strategies targeting it, such as sialic acid mimetics, antibody drug conjugates or CAR-T cell therapy, are becoming an emerging direction in cancer treatment, aiming to block metastasis or enhance immune surveillance.

Potential applications of neuroscience and regenerative medicine

Sialylated sugar chains are highly enriched in the nervous system and are involved in synaptic plasticity, myelination, and neuroprotection. Studies have shown that changes in the structure of 3-sialogalactose are related to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, possibly by affecting amyloid aggregation or neuroinflammatory pathways. In regenerative medicine, this structure can be used to modify biomaterial scaffolds to simulate natural extracellular matrix to enhance stem cell adhesion, differentiation and tissue repair capabilities, providing new ideas for nerve regeneration or organ engineering.

Key building blocks of glycoengineering and synthetic biology

As a standard or synthetic precursor, 3-sialogalactose (sodium salt) plays an important role in the chemoenzymatic synthesis of complex sugar chains. It can be used to construct glycovaccines, glycosylated antibodies or glycomimetic materials to promote the development of personalized medicine and drug delivery systems. For example, in the design of tumor vaccines, the introduction of this structure can simulate tumor-associated antigens and stimulate specific immune responses; in enzyme replacement therapy, optimizing the glycosylation pattern can improve the pharmacokinetics of therapeutic proteins.

Conclusion

3-Sialyl galactose (sodium salt) is not only a simple sugar molecule, but also a bridge connecting basic science and clinical applications. From deciphering cell communication codes to fighting infectious diseases, from cancer intervention to nerve repair, its multi-dimensional functions are constantly being discovered. With the advancement of glycomics, structural biology and nanotechnology, this oligosaccharide unit will surely empower the next generation of biomedical innovation, open up new possibilities for disease diagnosis, prevention and treatment, and play an indispensable role in the era of precision medicine.

The above information is provided by the editor of KASONS and is for scientific research only.